TNFRSF1B and cystic fibrosis: Our results indicate that etanercept could be effective in preventing the LTα3-TNFR2 interaction, reducing apoptosis, and increasing airway epithelial cell survival, particularly within the chronic hyperoxidant environment of the CF airways.